I am back home in Denver and catching up on all my thoughts from AHIP 2008. Every year I come back wishing I could divide my time exponentially. After all, a quick count of this year’s session tells me that I could only scratch the surface. In total, the Institute offered 6 Keynote/General Sessions; 6 Workshops ranging form 2-6 hours in length; 31 concurrent 60-90 minute sessions and 11 breakfast symposiums. You do the math. Nevertheless, I hope you’ve found this blog around AHIP 2008 to be informative, insightful and useful.

As there was only one of me, you tell me – What was your “moment of insight”?
What sessions did you find of most value?

Will there be substantive change in the healthcare system come the next administration?

What do you see as being the definition of “Healthcare 2.0”?

What are you tired of as far as topics at these huge healthcare conferences? What do you crave more of? Should conferences seek to always address healthcare quality, cost, outcomes, and satisfaction? Should more or fewer conferences be targeted for both payers and providers?

What will it take to get the Plan and Provider communities to collaborate better? Do they need to?

Must P4P and Tier-Networks take a backseat in order to first advance measurement of adherence to Evidence-Based Medicine?

I missed Steven Levitt’s “The Freakonomics of Health Care”! The cab ride to the airport was a necessary but pathetic substitute. What did you get out of it? What should I know?!

Keeping constructive and insightful thoughts to oneself never contributes to collaboration. Please post your comments and I will continue thru the year to share bits and pieces of relevant insight as they come across this “healthcare 2.0” yet “50something” brain!



About Author

Rick Ingraham

Principal Industry Consultant

Rick has served as Health Intelligence Officer within SAS Federal, LLC since April 2011. He presents 20+ years of executive-level health experience in both the provider and payer settings and served SAS as senior healthcare strategist for 1998 to 2008. He served as global health & life sciences director within Teradata until rejoining SAS in 2011

Comments are closed.

Back to Top